Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.
Medtronic announced today that it received FDA clearance for its new InPen insulin delivery system application.
Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...